GlaxoSmithKline to manufacture Novavax Covid-19 vaccine in UK, securing local supply

• The agreement has the potential to reduce the UK’s reliance on overseas vaccine supplies amid a dispute with the EU over exports
• PM Boris Johnson said Britain is building up its long-term manufacturing capabilities, and is on track to offer a first vaccine dose to all adults by late July